What are the efficacy and functions of valganciclovir/vansevir?

Valganciclovir is an important antiviral prescription drug mainly used to treat cytomegalovirus (CMV)-related diseases. Cytomegalovirus belongs to the herpes virus family and often manifests as latent infection in people with normal immune function. However, in people with low immune function, such as AIDS patients, organ transplant recipients, or patients receiving immunosuppressive therapy, it may cause severe viral replication and organ damage. Valganciclovir is the key drug to provide protection and treatment for this high-risk group.

From a pharmacological point of view, valganciclovir is an oral prodrug of ganciclovir (Ganciclovir), which is rapidly converted into the active form after absorption through the intestines in the body. Compared with direct use of ganciclovir injections, valganciclovir has better oral bioavailability, allowing patients to obtain stable blood drug concentrations through oral administration, thereby avoiding the inconvenience of frequent intravenous infusions. This feature significantly improves patient compliance and treatment sustainability.

In clinical application, the efficacy of valganciclovir mainly focuses on two aspects. One is to treat confirmed CMV infections, such as CMV enteritis, pneumonia or retinitis, which are common in organ transplant patients. By inhibiting the synthesis of viral DNA, it can effectively prevent viral replication, reduce tissue damage, and reduce the risk of disease progression. The second is to prevent CMV infection in high-risk groups, especially in the early stages after kidney, heart or liver transplantation. Use as preventive medication can significantly reduce the incidence of CMV reactivation and improve graft survival and patient long-term prognosis.

In addition, valganciclovir also plays an important role in the treatment of AIDS combined withCMV retinitis. CMV retinitis can rapidly progress to blindness if left untreated. A course of oral valganciclovir can not only control viral activity, but also delay the progression of lesions, providing patients with valuable time to preserve their vision.

Reference materials:https://go.drugbank.com/drugs/DB01610